Trading Window

Date: 25th June 2026 National Stock Exchange of India BSE Limited Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers Dalal Bandra Kurla Complex, Bandra (E), Street, Mumbai – 400001 Mumbai – 400051 Scrip Code: 544619 Scrip Symbol- SUDEEPPHRM Sub: Closure of Trading Window for dealing in securities of the Company in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended (“SEBI PIT Regulations”) Dear Sir/Madam, Pursuant to the Code of Conduct on Prevention of Insider Trading of Sudeep Pharma Limited (“the Company”) and SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company shall be closed for designated persons from Wednesday, 1st July 2026 and shall remain closed till 48 hours after the declaration of the un-audited financial results of the Company for quarter ending on 30th June 2026 and other matters, if any. Accordingly, all Designated Persons and their immediate relatives, directly or indirectly, are prohibited to deal in the securities of the Company during this period. The date of the meeting of the Board of directors to approve the un-audited financial results of the company for the aforementioned quarter, shall be informed to the stock exchanges in due course. This is for your information and records. Sincerely, For Sudeep Pharma Limited Dimple Mehta Company Secretary & Compliance Officer M. No: F13184 CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com